Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Mapping genes that predict treatment outcome in admixed populations.

Baye TM, Wilke RA.

Pharmacogenomics J. 2010 Dec;10(6):465-77. doi: 10.1038/tpj.2010.71. Epub 2010 Oct 5.

2.

Clinical pharmacogenetics and potential application in personalized medicine.

Zhou SF, Di YM, Chan E, Du YM, Chow VD, Xue CC, Lai X, Wang JC, Li CG, Tian M, Duan W.

Curr Drug Metab. 2008 Oct;9(8):738-84. Review.

PMID:
18855611
3.

Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.

Kirchheiner J, Seeringer A.

Biochim Biophys Acta. 2007 Mar;1770(3):489-94. Epub 2006 Oct 4. Review.

PMID:
17113714
4.

Genetic polymorphisms associated with antiepileptic metabolism.

Lopez-Garcia MA, Feria-Romero IA, Fernando-Serrano H, Escalante-Santiago D, Grijalva I, Orozco-Suarez S.

Front Biosci (Elite Ed). 2014 Jun 1;6:377-86. Review.

PMID:
24896213
5.

Race, ethnicity, ancestry, and pharmacogenetics.

Urban TJ.

Mt Sinai J Med. 2010 Mar-Apr;77(2):133-9. doi: 10.1002/msj.20168. Review.

PMID:
20309922
6.

Pharmacogenetics and cardiovascular disease--implications for personalized medicine.

Johnson JA, Cavallari LH.

Pharmacol Rev. 2013 May 17;65(3):987-1009. doi: 10.1124/pr.112.007252. Print 2013 Jul. Review.

7.

Pharmacogenomics in the Americas: the impact of genetic admixture.

Suarez-Kurtz G, Pena SD.

Curr Drug Targets. 2006 Dec;7(12):1649-58. Review.

PMID:
17168840
8.

The pharmacogenetics of the response to warfarin in Chinese.

Lam MP, Cheung BM.

Br J Clin Pharmacol. 2012 Mar;73(3):340-7. doi: 10.1111/j.1365-2125.2011.04097.x. Review.

9.

Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms.

Daly AK.

Arch Toxicol. 2013 Mar;87(3):407-20. doi: 10.1007/s00204-013-1013-9. Epub 2013 Feb 2. Review.

PMID:
23376975
10.

Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin.

Fung E, Patsopoulos NA, Belknap SM, O'Rourke DJ, Robb JF, Anderson JL, Shworak NW, Moore JH.

Semin Thromb Hemost. 2012 Nov;38(8):893-904. doi: 10.1055/s-0032-1328891. Epub 2012 Oct 6. Review. Erratum in: Semin Thromb Hemost. 2013 Feb;39(1):112.

11.

Cytochrome P450 2C9-CYP2C9.

Van Booven D, Marsh S, McLeod H, Carrillo MW, Sangkuhl K, Klein TE, Altman RB.

Pharmacogenet Genomics. 2010 Apr;20(4):277-81. doi: 10.1097/FPC.0b013e3283349e84. Review. No abstract available.

12.

Expanding role of pharmacogenomics in the management of cardiovascular disorders.

Yip VL, Pirmohamed M.

Am J Cardiovasc Drugs. 2013 Jun;13(3):151-62. doi: 10.1007/s40256-013-0024-5. Review.

PMID:
23579966
13.

Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles.

Oldenburg J, Bevans CG, Fregin A, Geisen C, Müller-Reible C, Watzka M.

Thromb Haemost. 2007 Sep;98(3):570-8. Review.

PMID:
17849045
14.

The pharmacogenetics of CYP2C9 and CYP2C19: ethnic variation and clinical significance.

Rosemary J, Adithan C.

Curr Clin Pharmacol. 2007 Jan;2(1):93-109. Review.

PMID:
18690857
15.

Pharmacogenetics of oral anticoagulants.

Rojas JC, Aguilar B, Rodríguez-Maldonado E, Collados MT.

Blood Coagul Fibrinolysis. 2005 Sep;16(6):389-98. Review.

PMID:
16093729
16.

Pharmacogenetics guided anticoagulation.

Sunder-Plassmann R, Mannhalter C.

Clin Chem Lab Med. 2010 Dec;48 Suppl 1:S119-27. doi: 10.1515/CCLM.2010.370. Epub 2010 Nov 10. Review.

PMID:
21062219
17.

[Possible application of pharmacogenomics to warfarin therapy].

Murata M.

Rinsho Byori. 2011 Jun;59(6):594-7. Review. Japanese.

PMID:
21815482
18.

10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal.

Kurnik D, Loebstein R, Halkin H, Gak E, Almog S.

Pharmacogenomics. 2009 Dec;10(12):1955-65. doi: 10.2217/pgs.09.149. Review.

PMID:
19958094
19.

[Cancer pharmacogenetics: study of genetically determined variations on cancer susceptibility due to xenobiotic exposure].

Quiñones L, Lee K, Varela F N, Escala M, García K, Godoy L, Castro A, Soto J, Saavedra I, Cáceres D.

Rev Med Chil. 2006 Apr;134(4):499-515. Epub 2006 May 25. Review. Spanish.

20.

Pharmacogenetics-based warfarin dosing in children.

Hamberg AK, Wadelius M.

Pharmacogenomics. 2014 Feb;15(3):361-74. doi: 10.2217/pgs.14.8. Review.

Supplemental Content

Support Center